Michael D. West

Cell biology

United States
Also Known As
CEO, AgeX Therapeutics (NYSE American:AGE)

Michael D. West, Ph.D., is the founder and CEO of AgeX Therapeutics, Inc. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular ageing. He has focused his academic and business career on the application of developmental biology to age-related degenerative disease. He was the founder and first CEO of Geron Corporation (Nasdaq: GERN), and from 1992 to 1998, he held various positions, including CEO, Director, and Vice President. From 1998 to 2007, Dr West held positions as CEO, President, and Chief Scientific Officer at Advanced Cell Technology, Inc. (ACT), which was eventually acquired by Astellas Pharma, Inc. From 2007 to 2018, he was CEO/Co-CEO of BioTime, Inc. (NYSE American: BTX). https://www.bloomberg.com/press-releases/2021-03-18/cps-health-care-and-telewellness-present-the-rating-of-covid-technologies-on-a-lifetime-award

Voted (0)

Works (0)

Video (0)

News about Michael D. West(0)

Join our Telegram Channel!